One of These Growth ETFs Has a 10-Year Record. The Other Is Beating It Anyway.

Invesco NASDAQ 100 ETF (QQQM) outperformed Vanguard Growth ETF (VUG) across all valid overlapping periods, returning 21.25% YTD, 24.57% over one year, and 107.63% over five years, versus VUG's 12.27%, 14.24%, and 86.65%, respectively. QQQM's performance reflects concentrated exposure to mega-cap Nasdaq technology, but its live history begins only in October 2020 and it carries a 0.15% expense ratio versus VUG's 0.03%. The article favors QQQM for long-horizon Roth IRA investors able to withstand concentration risk, while VUG offers broader sector diversification and a lower-cost alternative if market leadership broadens beyond Nasdaq mega-cap technology.

Analysis

The apparent relative-performance debate is economically a concentration-factor choice, not a durable fund-selection edge. QQQM carries more pure Nasdaq mega-cap and semiconductor beta, while VUG adds incremental exposure to growth leadership outside that listing ecosystem; their shared ownership of the largest AI/platform names means a long/short ETF pair will have limited idiosyncratic alpha and substantial common-factor risk. The relevant catalyst over the next 1-3 months is whether earnings revisions continue to concentrate in NVDA, AVGO, MSFT and hyperscaler capex beneficiaries; if so, QQQM’s narrower exposure should retain momentum.

The fee differential matters more than recent return tables imply: a 12bp annual drag compounds to roughly 1.2% over a decade before any reinvestment effects. QQQM must therefore generate persistent gross index excess return merely to break even with VUG, raising the hurdle if AI capex normalizes or leadership broadens into healthcare, consumer, industrial automation, or NYSE-listed growth. LLY is a useful marker for that rotation: sustained relative strength in LLY versus the semiconductor complex would favor VUG’s diversification profile.

For IVZ, asset retention and net inflows into QQQM are the monetizable implication, not the ETF’s relative return alone; at the reported asset base, the 15bp fee pool is material recurring revenue, though the incremental impact from this article is not tradeable. Contrarian risk is that investors extrapolate a concentrated growth regime after the underlying constituents have already absorbed optimistic AI earnings assumptions. A reversal would likely first appear through falling semiconductor earnings revisions, weaker cloud capex commentary, or NVDA/AVGO underperformance rather than a broad equity selloff.

Key Decisions for Investors

• Do not initiate a standalone QQQM-versus-VUG pair solely on trailing returns; treat it as a tactical factor expression, not a dispersion trade, because common mega-cap exposure will dominate P&L.
• For a 1-3 month pro-AI-capex view, overweight QQQM or QQQ against VUG only after confirming continued upward FY earnings revisions for NVDA, AVGO, MSFT and AMZN; exit the relative tilt if the semiconductor revision breadth turns negative for two consecutive weeks.
• For a 6-18 month strategic growth allocation, favor VUG over QQQM when expected gross return dispersion is unclear: the 12bp annual cost advantage provides a modest but certain carry edge and reduces dependence on a single exchange/sector complex.
• Monitor LLY relative to NVDA and AVGO as a leadership-rotation trigger. If LLY materially outperforms the semiconductor basket alongside declining AI-capex estimates, rotate any QQQM overweight back toward VUG rather than adding broad market beta.
• Keep IVZ on a flow watch rather than buying on this signal. A sustained rise in QQQM net creations over multiple monthly reporting periods would support fee-revenue estimates; without verified flows, the revenue implication is insufficient for an IVZ position.